Literature DB >> 22966395

Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer.

Fumitoshi Terauchi1, Aikou Okamoto, Yumiko Wada, Ei Hasegawa, Toru Sasaki, Osamu Akutagawa, Yasukazu Sagawa, Hirotaka Nishi, Keiichi Isaka.   

Abstract

Surgical resections, such as peritoneal stripping (peritonectomy) are performed for disseminated diaphragmatic lesions of advanced ovarian cancer. This study retrospectively investigated the incidental events of diaphragmatic surgery. The records of patients with advanced mullerian carcinomas, including ovarian, primary peritoneal and fallopian carcinomas, who underwent diaphragmatic surgery were reviewed. Based on our criteria, stripping was performed for surface disease on the diaphragm, and full-thickness resection was performed for bulky disease. In certain cases, both procedures were performed. We analyzed intra- and post-operative incidental events in 82 patients. The χ(2) and Fisher's exact tests were used in the statistical analysis. There were 82 stage III-IV cases of which 56 patients underwent stripping, 12 underwent full-thickness resection and 14 patients underwent both procedures. Unexpected open chest surgery following stripping occurred in 1 out of 63 patients (1.6%) in the primary, 4 out of 13 patients (30.8%) in the interval and 0 out of 6 patients (0.0%) in the secondary debulking surgery groups. The incidence of unexpected open chest surgery was high in the interval debulking surgery group (p<0.001). Regarding post-operative events, accumulation of pleural effusion was identified in 43 patients (52.4%). The incidence of pleural effusions was not significantly different between the two procedures. No complications were encountered, nor was a chest tube required, during unexpected open chest surgery and postoperative pleural effusions. Therefore, it was concluded that special attention should be paid during interval debulking surgery even though it was possible for surgical resections of diaphragmatic lesions to be performed safely.

Entities:  

Year:  2010        PMID: 22966395      PMCID: PMC3436412          DOI: 10.3892/ol_00000152

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.

Authors:  Giovanni D Aletti; Sean C Dowdy; Karl C Podratz; William A Cliby
Journal:  Gynecol Oncol       Date:  2005-09-22       Impact factor: 5.482

2.  Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer.

Authors:  Jalid Sehouli; Filiz Senyuva; Christina Fotopoulou; Ulf Neumann; Carsten Denkert; Lichtenegger Werner; Oskay-Ozcelik Gülten
Journal:  J Surg Oncol       Date:  2009-06-01       Impact factor: 3.454

3.  Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer.

Authors:  Eric L Eisenhauer; Michael I D'Angelica; Nadeem R Abu-Rustum; Yukio Sonoda; William R Jarnagin; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2006-07-03       Impact factor: 5.482

4.  The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.

Authors:  Eric L Eisenhauer; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Elizabeth A Poynor; Carol Aghajanian; William R Jarnagin; Ronald P DeMatteo; Michael I D'Angelica; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2006-08-04       Impact factor: 5.482

5.  What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

Authors:  D S Chi; E L Eisenhauer; J Lang; J Huh; L Haddad; N R Abu-Rustum; Y Sonoda; D A Levine; M Hensley; R R Barakat
Journal:  Gynecol Oncol       Date:  2006-05-22       Impact factor: 5.482

6.  Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature.

Authors:  Margrit M Juretzka; Faith R Horton; Nadeem R Abu-Rustum; Yukio Sonoda; William R Jarnagin; Raja M Flores; Richard Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2005-10-14       Impact factor: 5.482

7.  The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Authors:  Oliver Zivanovic; Eric L Eisenhauer; Qin Zhou; Alexia Iasonos; Paul Sabbatini; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2007-11-13       Impact factor: 5.482

8.  Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

Authors:  Dennis S Chi; Corinna C Franklin; Douglas A Levine; Faina Akselrod; Paul Sabbatini; William R Jarnagin; Ronald DeMatteo; Elizabeth A Poynor; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

9.  Pilot study on transdiaphragmatic thoracoscopic-assisted pleural biopsy and intrathoracic washing cytology for Stage IIIc ovarian cancer with diaphragmatic metastases.

Authors:  Fumitoshi Terauchi; Yukari Kobayashi; Takeo Nagashima; Tetsuya Moritake; Hirotaka Nishi; Atsuya Fujito; Keiichi Isaka
Journal:  Int J Gynecol Cancer       Date:  2009-02       Impact factor: 3.437

10.  Role of diaphragmatic surgery in 69 patients with ovarian carcinoma.

Authors:  K Devolder; F Amant; P Neven; T van Gorp; K Leunen; I Vergote
Journal:  Int J Gynecol Cancer       Date:  2008 Mar-Apr       Impact factor: 3.437

View more
  1 in total

1.  Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer.

Authors:  Roberto Caronna; Paolo Sammartino; Maria Luisa Framarino; Bianca Maria Sollazzo; Roberto Luca Meniconi; Piero Chirletti
Journal:  World J Surg Oncol       Date:  2013-09-23       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.